BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  “Thousands of Jobs” Reportedly on the Block as Novartis Restructures

  Novartis announced a global restructuring that will include cutting thousands of jobs. The restructuring is intended to effectively merge two divisions within Novartis into one.

  April 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Drug Development

  Takeda Touts Positive Pediatric Data in Competitive HAE Space

  The trial demonstrated a safety profile in the younger age group as seen in patients 12 and older, with no severe side effects and no one dropping out from adverse events.

  April 12, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Myovant Stumbles on FDA Concerns Over Pfizer-Partnered Endometriosis Drug

  Myovant said that the FDA provided notice it had found deficiencies that will preclude any potential discussion of labeling or post-marketing requirements at this time.

  April 12, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  It’s All MDS and AML Trials Go for Gilead as FDA Lifts Partial Hold

  The FDA’s decision to lift the hold directive on April 11 involving the investigational drug magrolimab follows a comprehensive review of each trial’s safety data.

  April 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Moderna Celebrates Appointment of New CFO, Recalls Vaccine Lots in Europe

  Moderna tapped Jorge Gomez to take over the role of chief financial officer next month upon the retirement of David Meline, the current company CFO.

  April 12, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Aurion Biotech Pots $120M to Advance Cell Therapy for Eye Diseases

  The funding will be used to push forward Aurion’s cell therapy program for corneal edema secondary to endothelial dysfunction.

  April 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Aeglea Presents Robust Data in Rare Metabolic Disorder, Submits First BLA

  As Aeglea presents the data this week at the Society for Inherited Metabolic Disorders (SIMD), its stock has responded to both announcements with a strong leap.

  April 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  Novartis Highlights Early Data from Potential Lumakras Competitor at AACR

  Although the data was preliminary from a Phase Ib trial, investors are already speculating that the drug - when and if it makes it to regulators - could compete with Amgen’s Lumakras (sotorasib).

  April 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  JAMA Taps Health Equity Champion Kirsten Bibbins-Domingo as Editor-in-Chief

  Kirstin Bibbins-Domingo takes over on July 1 and will become the first African American to helm the prestigious medical journal.

  April 12, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Cimeio Therapeutics Wins $50M to Power Cell-Shielding Technology

  Cimeio Therapeutics, a novel cell therapy startup, announced the completion of a $50 million Series A financing round Wednesday morning.

  April 12, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh